Physician profile
John C Mitchell
NPI 1912972191
$237.81
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63.89 · 2020: $24.74 · 2021: $48.97 · 2022: $29.04 · 2023: $31.81 · 2024: $39.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $71.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $71.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $34.28 | 2019-2024 | Entyvio |
| Abbvie INC. | $32.81 | 2022-2023 | |
| Lilly USA, LLC | $25.07 | 2024 | Omvoh |
| Qol Medical, LLC | $24.74 | 2020 | |
| Amgen INC. | $17.59 | 2021 | |
| Janssen Biotech, INC. | $17.29 | 2019 | |
| Welch Allyn | $16.90 | 2021 | |
| Pfizer INC. | $15.44 | 2019 | |
| Celgene Corporation | $15.37 | 2023 | Zeposia |
| Ferring Pharmaceuticals INC. | $14.48 | 2021 | |
| Baxter Healthcare | $12.67 | 2022 | |
| Gilead Sciences, INC. | $11.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.